Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3171-3184
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3171
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3171
Adjuvant chemotherapy for isolated resectable colorectal lung metastasis: A retrospective study using inverse probability treatment weighting propensity analysis
Zhao Gao, Shi-Kai Wu, Xuan Jin, Department of Medical Oncology, Peking University First Hospital, Beijing 100034, China
Shi-Jie Zhang, Department of Thoracic Surgery, Peking University First Hospital, Beijing 100034, China
Xin Wang, Ying-Chao Wu, Department of Gastrointestinal Surgery, Peking University First Hospital, Beijing 100034, China
Author contributions: Gao Z and Jin X prepared the manuscript; Wu SK, Wang X and Jin X conceived the review, and edited the manuscript; Gao Z collected and analyzed the data; Zhang SJ and Wu YC analyzed the data and drafted the manuscript; All the authors have read and approved the final version of the manuscript.
Supported by the National Project for Clinical Key Specialty Development.
Institutional review board statement: Our study complies with all ethical regulations of the Peking University First Hospital Ethics Committee, Approval No. 2024-321-001.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Data sharing statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xuan Jin, PhD, Department of Medical Oncology, Peking University First Hospital, No. 8 Xishiku Street, Beijing 10034, China. jinxuanbdyy@outlook.com
Received: May 11, 2024
Revised: August 17, 2024
Accepted: August 29, 2024
Published online: October 27, 2024
Processing time: 139 Days and 6.5 Hours
Revised: August 17, 2024
Accepted: August 29, 2024
Published online: October 27, 2024
Processing time: 139 Days and 6.5 Hours
Core Tip
Core Tip: It remains controversial whether patients who have reached no evidence disease after resection of pulmonary metastasis of colorectal cancer (CRC) can benefit from adjuvant chemotherapy (ACT). We aimed to evaluate the efficacy of ACT in patients after resection of pulmonary metastasis resection from CRC. Due to the lack of randomized prospective trials and high level evidence, our study may support valuable data support for individual participant data meta-analysis and help further research on this type of disease.